Abstract
Introduction: The incidence of new cancer cases globally could reach 30 million in the coming decades, in which the usual oncological treatment - UOT (chemotherapy, radiotherapy and surgery) may be associated with a decrease in quality of life (QoL) and the emergence of comorbidities due to its adverse effects. Aim: to evaluate the quality of life and symptoms of individuals undergoing ca…